The invention pertains to the use of non-steroidal anti-inflammatory drugs in cases of diseases of the upper respiratory tract and of polyposis, especially for suppressing leukotriene production, principally that of chemotactically active LTB4, as well as prostaglandin and thromboxane production by inhibiting the enzyme activity of phospholipases, lipoxygenases and/or cyclooxygenases.
展开▼